Back |
home / stock / virx / virx message board
Subject | By | Source | When |
---|---|---|---|
chartguy89: SNSS Stock Charts Tuesday, November 18, 2014 12:11:27 PM $SNSS Sunesis Pharmaceuticals I | chartguy89 | investorshangout | 11/18/2014 5:11:24 PM |
leahanne: Volume Alert - SNSS 2.21 Sunesis Pharmaceuticals $SNSS Hit a high today of 2.49 Closing th | leahanne | investorshangout | 11/18/2014 5:07:00 PM |
danrocks: Right now SNSS is number 7 for the largest percentage gain out of 250 stocks. $SNSS SNSS i | danrocks | investorshangout | 11/18/2014 3:20:37 PM |
clayton: SNSS 2.20 Sunesis Pharmaceuticals $SNSS added to my watch list. Right now with SNSS I am wa | clayton | investorshangout | 11/18/2014 2:52:06 PM |
Jake13: SNSS Year to date has changed -51.27% percent. +60.42% in the last 30 days. $SNSS Sunesis Ph | Jake13 | investorshangout | 11/18/2014 10:41:24 AM |
chartguy89: SNSS 2.31 Sunesis Pharmaceuticals Stock Charts $SNSS Last Updated: 11/17/14 Last price: | chartguy89 | investorshangout | 11/18/2014 10:13:14 AM |
News, Short Squeeze, Breakout and More Instantly...
Viracta Therapeutics Inc. Company Name:
VIRX Stock Symbol:
NASDAQ Market:
Viracta Therapeutics Inc. Website:
SAN DIEGO, May 17, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that, in connection with the appointment of Mi...
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced the appointment of Michael Faerm as Chief Financia...